Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (17) Birchmeier, Walter Prof. Dr. (19) Birchmeier-Kohler, Carmen Prof. Dr. (13) Dechend, Ralf Priv. Doz. (5) Gerhardt, Holger Prof. Dr. (4) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (7) Ivics, Zoltan Dr. (6) Izsvak, Zsuzsanna Dr. (6) Jandrig, Burkhard Dr. (1) Jentsch, Thomas Prof. Dr. (14) Kemmner, Wolfgang PD Dr. (1) Kettenmann, Helmut Prof. Dr. (23) Kettritz, Ralph Prof. Dr. (4) Klußmann, Enno PD Dr. (1) Koch, Gudrun (2) Kowenz-Leutz, Elisabeth Dr. (1) Kühn, Ralf Dr. (6) Landthaler, Markus Prof. Dr. (1) Lewin, Gary Prof. Dr. (8) Luft, Friedrich Prof. Dr. (91) Morano, Ingo Prof. Dr. (12) Müller, Dominik Prof. Dr. (4) Niendorf, Thoralf Prof. Dr. (3) Nolte, Christiane Dr. (1) Ohler, Uwe Prof. Dr. (2) Perrot, Andreas (1) Pezzutto, Antonio Prof. Dr. (1) Potente, Michael Prof. Dr. (1) Rahn, Hans-Peter Dr. (1) Rajewsky, Klaus Prof. Dr. (3) Rajewsky, Nikolaus Prof. Dr. (3) Rathjen, Fritz Prof. Dr. (1) Reich, Jens Prof. Dr. (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (6) Schlag, Peter M. Prof. Dr. (10) Schmitz, Dietmar Prof. Dr. (10) Schulz-Menger, Jeanette Prof. Dr. (2) Selbach, Matthias Prof. Dr. (2) Sporbert, Anje Dr. (1) Spuler, Simone Prof. (3) Wallukat, Gerd Dr. (1) Wanker, Erich Prof. Dr. (11) Wunderlich, Volker Prof. Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (10) (-) Leutz, Achim Prof. Dr. (7) 1992 (7) 1993 (9) 1994 (9) (-) 1995 (11) 1996 (7) 1997 (13) 1998 (10) (-) 1999 (6) 2000 (9) 2001 (10) 2002 (8) 2003 (12) 2004 (14) 2005 (12) 2006 (5) 2007 (6) 2008 (8) 2009 (4) 2010 (13) 2011 (8) 2012 (11) 2013 (16) 2014 (7) 2015 (6) 2016 (7) 2017 (9) 2018 (6) 2019 (8) 2020 (4) 2021 (1) Cell Differentiation and Tumorigenesis (7) Molecular Immunology and Gene Therapy (10) Molecular Immunotherapy (1) Signal Transduction in Tumor Cells (2) 17 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Leutz, Achim Prof. Dr.19951999 Sort: Result score Newest to oldest Oldest to newest November 01, 1999 in Mol Cell A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes E. Kowenz-Leutz A. Leutz September 28, 1999 in Circulation Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis R. Dechend M. Maass J. Gieffers R. Dietz C. Scheidereit A. Leutz D.C. Gulba June 22, 1999 in Proc Natl Acad Sci U S A Separation of C/EBP alpha-mediated proliferation arrest and differentiation pathways C. Mueller M. Alunni-Fabroni E. Kowenz-Leutz X.M. Mo M. Tommasino A. Leutz June 03, 1999 in Oncogene The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel and nuclear co-regulators R. Dechend F. Hirano K. Lehmann V. Heissmeyer S. Ansieau F.G. Wulczyn C. Scheidereit A. Leutz March 01, 1999 in J Exp Med T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice T. Schueler Z. Qin S. Ibe N. Noben-Trauth T. Blankenstein January 01, 1999 in Eur J Immunol Direct and indirect T cell priming by dendritic cell vaccines S. Cayeux G. Richter C. Becker A. Pezzutto B. Doerken T. Blankenstein December 21, 1995 in Oncogene The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo P. Dhordain O. Albagli S. Ansieau M. Koken C. Deweindt S. Quief D. Lantoine A. Leutz J.P. Kerckaert D. Leprince January 01, 1995 in Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein January 01, 1995 in Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein January 01, 1995 in J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling Pagination Current page 1 Page 2 Next page Next › Last page Last »
November 01, 1999 in Mol Cell A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes E. Kowenz-Leutz A. Leutz
September 28, 1999 in Circulation Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis R. Dechend M. Maass J. Gieffers R. Dietz C. Scheidereit A. Leutz D.C. Gulba
June 22, 1999 in Proc Natl Acad Sci U S A Separation of C/EBP alpha-mediated proliferation arrest and differentiation pathways C. Mueller M. Alunni-Fabroni E. Kowenz-Leutz X.M. Mo M. Tommasino A. Leutz
June 03, 1999 in Oncogene The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel and nuclear co-regulators R. Dechend F. Hirano K. Lehmann V. Heissmeyer S. Ansieau F.G. Wulczyn C. Scheidereit A. Leutz
March 01, 1999 in J Exp Med T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice T. Schueler Z. Qin S. Ibe N. Noben-Trauth T. Blankenstein
January 01, 1999 in Eur J Immunol Direct and indirect T cell priming by dendritic cell vaccines S. Cayeux G. Richter C. Becker A. Pezzutto B. Doerken T. Blankenstein
December 21, 1995 in Oncogene The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo P. Dhordain O. Albagli S. Ansieau M. Koken C. Deweindt S. Quief D. Lantoine A. Leutz J.P. Kerckaert D. Leprince
January 01, 1995 in Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein
January 01, 1995 in Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein
January 01, 1995 in J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling
